5

Sarda Proteins

SARDAPROTEINSLTD NSE

Key Fundamentals

MicrocapFMCG ProductsFMCG
Market Cap
₹101 Cr
Volatility
High Risk
P/E Ratio
34.5
EBITDA
₹0.29 Cr
Return on Equity
0.21%
Debt to Equity
0.05
Book Value
₹10.57
52W High
₹137.1
52W Low
₹59.95

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company is almost debt free.
  • Promoter holding has increased by 80.7% over last quarter.

Weaknesses

4
  • Stock is trading at 33.6 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 9.02% over last 3 years.
  • Earnings include an other income of Rs.5.83 Cr.

Growth Rate

Revenue Growth
-33.22% lower than 3Y
Net Income Growth
813% higher than 3Y
Cash Flow Change
52.17% lower than 3Y
ROE
-74.39% lower than 3Y
ROCE
6.33% lower than 3Y
EBITDA Margin (Avg.)
—

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.24
0
1
0.06
0
0.14
24.05
0
10.95
4.3
0.25
0.65
12.99
Expenses
0.28
0.05
1.03
0.08
0.08
0.03
23.95
0.1
11.44
4.01
0.37
0.05
16.26
Operating Profit
-0.04
-0.05
-0.03
-0.02
-0.08
0.11
0.1
-0.1
-0.49
0.29
-0.12
0.6
-3.27
OPM %
-16.67%
—
-3%
-33.33%
—
78.57%
0.42%
—
-4.47%
6.74%
-48%
92.31%
-25.17%
Other Income
0.04
0.04
0.04
0.04
0
0
0
0
0
0.11
0
0.24
5.48
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
-0.01
0.01
0.02
-0.08
0.11
0.1
-0.1
-0.49
0.4
-0.12
0.84
2.21
Tax %
—
0%
0%
0%
0%
0%
0%
20%
0%
0%
0%
0%
24.89%
Net Profit
0
-0.01
0.01
0.02
-0.08
0.11
0.1
-0.11
-0.49
0.4
-0.12
0.84
1.66
EPS in Rs
0
-0.06
0.06
0.12
-0.46
0.64
0.58
-0.64
-2.84
2.32
-0.7
0.94
1.85
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
5.02
2.06
6.18
5.65
7.22
5.4
11.36
10.76
5.8
1.3
24.19
16.16
18.19
Expenses
5.14
2.18
6.35
6
7.33
5.31
11.38
10.5
5.95
1.45
24.17
15.87
20.69
Operating Profit
-0.12
-0.12
-0.17
-0.35
-0.11
0.09
-0.02
0.26
-0.15
-0.15
0.02
0.29
-2.5
OPM %
-2.39%
-5.83%
-2.75%
-6.19%
-1.52%
1.67%
-0.18%
2.42%
-2.59%
-11.54%
0.08%
1.79%
-13.74%
Other Income
0.8
0
0
-0.01
0.03
0.08
0.08
0.09
0.16
0.17
0
0.35
5.83
Interest
0.02
0.03
0.01
0
0
0
0
0
0
0
0
0
0
Depreciation
0.04
0.02
0.01
0.01
0.01
0
0
0
0
0
0
0
0
PBT
0.62
-0.17
-0.19
-0.37
-0.09
0.17
0.06
0.35
0.01
0.02
0.02
0.64
3.33
Tax %
4.84%
-5.88%
-31.58%
-10.81%
44.44%
82.35%
133.33%
14.29%
500%
0%
100%
0%
—
Net Profit
0.59
-0.15
-0.13
-0.33
-0.12
0.03
-0.02
0.31
-0.03
0.02
0.01
0.64
2.78
EPS in Rs
1.8
-0.87
-0.75
-1.91
-0.7
0.17
-0.12
1.8
-0.17
0.12
0.06
0.71
4.41
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.43
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
Reserves
0.3
0.15
0.02
-0.31
-0.44
-0.41
-0.43
-0.12
-0.15
-0.13
-0.13
0.51
Borrowings
0.21
0.61
0.2
0
0.01
0
0
0
0
0
0
0.16
Other Liabilities
0.2
0.21
0.2
0.13
0.12
0.06
0.07
0.07
0.05
0.07
0.28
83.44
Total Liabilities
3.14
3.47
2.92
2.32
2.19
2.15
2.14
2.45
2.4
2.44
2.65
86.61
Fixed Assets
0.1
0.06
0.05
0.03
0.02
0.01
0.01
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.01
0.01
0.01
0.01
0
0
0
0
0
0
0
0
Other Assets
3.03
3.4
2.86
2.28
2.17
2.14
2.13
2.45
2.4
2.44
2.65
86.61
Total Assets
3.14
3.47
2.92
2.32
2.19
2.15
2.14
2.45
2.4
2.44
2.65
86.61
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.72
-1.2
-0.09
0.48
-0.59
-0.05
-0.05
0.1
-0.3
-0.23
-0.11
-76.39
Investing
1.9
0.2
0
0.02
0.11
0.09
0.08
0.09
0.16
0.17
0
0.36
Financing
-0.13
0.37
-0.42
-0.2
0.01
-0.01
0
0
0
0
0.03
83.51
Net Cash Flow
1.05
-0.63
-0.51
0.3
-0.47
0.03
0.03
0.19
-0.14
-0.07
-0.08
7.48
Free Cash Flow
0.73
-1.18
-0.09
0.48
-0.59
-0.04
-0.05
0.1
-0.3
-0.23
-0.11
-76.38
CFO/OP
525
1,000
53
-134
536
-22
200
38
200
153
-550
-26,341
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
13.81
0
38.98
44.58
36.4
56.1
24.74
7.12
0
0
0
96.44
Inventory Days
32.7
324
64.41
28.64
0
0
0
0
0
0
0
0
Days Payable
0.76
0
0.61
0
—
—
—
—
—
—
—
—
Cash Conversion Cycle
45.75
324
103
73.22
36.4
56.1
24.74
7.12
0
0
0
96.44
Working Capital Days
65.44
252
108
76.23
83.92
115
55.91
64.45
130
604
33.95
-104
ROCE %
-5.93%
-4.52%
-6.02%
-14.66%
-5.63%
8.17%
2.88%
15.73%
0.42%
0.85%
0.84%
23.06%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sarda Proteins insights

56 extracted metrics + investor summaries across FY09–FY26.

Log in — free

Shareholding Pattern

Promot.80.66%Others1.42%Public17.92%As ofJun 2026

Documents

Frequently Asked Questions about Sarda Proteins

What does Sarda Proteins Ltd do?
Incorporated in 1991, Sarda Proteins Ltd deals in the trading of Solar Cells[1]
Where is Sarda Proteins Ltd (519242) listed?
Sarda Proteins Ltd trades as SARDAPROTEINSLTD on the NSE and under code 519242 on the BSE.
Which sector does Sarda Proteins Ltd belong to?
Sarda Proteins Ltd is classified under the FMCG sector, in the FMCG Products industry.
What is the market capitalisation of Sarda Proteins Ltd?
Sarda Proteins Ltd has a market capitalisation of ₹101.11 Cr, which places it in the Small Cap band.
What is the PE ratio of Sarda Proteins Ltd?
Sarda Proteins Ltd trades at a PE ratio of 34.50, against a book value of ₹10.57 per share.
What is the 52-week high and low of Sarda Proteins Ltd?
Over the last 52 weeks Sarda Proteins Ltd has traded between ₹59.95 and ₹137.1.
What is the Return on Equity (ROE) of Sarda Proteins Ltd?
Sarda Proteins Ltd reported a return on equity of 0.21%. Its debt-to-equity ratio is 0.05.

Company Information

Incorporated in 1991, Sarda Proteins Ltd deals in the trading of Solar Cells[1]

Website sardaproteins.in
Listed 2006-04-04
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/519242.md for Sarda Proteins Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in FMCG → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List